Search research articles
Contact Us
Filters
Showing results (31-40 of 131) with videos related to
Page
of 14
Sort By:
European Journal of Pharmacology
|
June 5, 2004
Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration
Jannine G Truong, Glen R Hanson, Annette E Fleckenstein
Neuropharmacology
|
October 7, 2004
The methamphetamine experience: a NIDA partnership
Glen R Hanson, Kristi S Rau, Annette E Fleckenstein
Addiction (Abingdon, England)
|
May 12, 2007
Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment
Trent J Volz, Annette E Fleckenstein, Glen R Hanson
The Journal of Organic Chemistry
|
September 15, 2010
Charged tags as probes for analyzing organometallic intermediates and monitoring cross-coupling reactions by electrospray-ionization mass spectrometry
Matthias A Schade, Julia E Fleckenstein, Paul Knochel, et al.
Annals of the New York Academy of Sciences
|
November 16, 2004
Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications
Glen R Hanson, Veronica Sandoval, Evan Riddle, et al.
European Journal of Pharmacology
|
December 9, 2003
The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity
Kamisha L Johnson-Davis, Annette E Fleckenstein, Diana G Wilkins
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 28, 2002
Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors
Verónica Sandoval, Evan L Riddle, Glen R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2003
Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits
Verónica Sandoval, Evan L Riddle, Glen R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1996
Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]
A E Fleckenstein, S Pögün, F I Carroll, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 29, 2008
Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation
Sarah J Farnsworth, Trent J Volz, Glen R Hanson, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 131) with videos related to
Sort By:
Page
of 14
European Journal of Pharmacology
|
June 5, 2004
Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration
Jannine G Truong, Glen R Hanson, Annette E Fleckenstein
Neuropharmacology
|
October 7, 2004
The methamphetamine experience: a NIDA partnership
Glen R Hanson, Kristi S Rau, Annette E Fleckenstein
Addiction (Abingdon, England)
|
May 12, 2007
Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment
Trent J Volz, Annette E Fleckenstein, Glen R Hanson
The Journal of Organic Chemistry
|
September 15, 2010
Charged tags as probes for analyzing organometallic intermediates and monitoring cross-coupling reactions by electrospray-ionization mass spectrometry
Matthias A Schade, Julia E Fleckenstein, Paul Knochel, et al.
Annals of the New York Academy of Sciences
|
November 16, 2004
Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications
Glen R Hanson, Veronica Sandoval, Evan Riddle, et al.
European Journal of Pharmacology
|
December 9, 2003
The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity
Kamisha L Johnson-Davis, Annette E Fleckenstein, Diana G Wilkins
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 28, 2002
Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors
Verónica Sandoval, Evan L Riddle, Glen R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 27, 2003
Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits
Verónica Sandoval, Evan L Riddle, Glen R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1996
Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]
A E Fleckenstein, S Pögün, F I Carroll, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 29, 2008
Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation
Sarah J Farnsworth, Trent J Volz, Glen R Hanson, et al.
Page
of 14